<![CDATA[The U.S. FDA has approved a drug that could extend the survival of people with metastatic pancreatic cancer.]]>The U.S. FDA has approved a drug that could extend the survival of people with metastatic pancreatic cancer. In a clinical trial, median overall survival doubled to more than 13 months compared to chemotherapy. Here's more from @abc.

https://flip.it/Rs6uDl

]]>https://postcall.pub/topic/bb6a74f2-9f63-4530-9fce-8d3e5d11ff8f/the-u.s.-fda-has-approved-a-drug-that-could-extend-the-survival-of-people-with-metastatic-pancreatic-cancer.RSS for NodeSun, 30 Aug 2026 12:11:27 GMTWed, 26 Aug 2026 17:54:00 GMT60<![CDATA[Reply to The U.S. FDA has approved a drug that could extend the survival of people with metastatic pancreatic cancer. on Wed, 26 Aug 2026 19:05:47 GMT]]>@ScienceDesk @abc It seems the usual overblown neoadjuvant drug, costly, difficult to obtain and linked with specific subset of patients. So far, we must admit that it is only a matter of mega-profits and less about survival of oncology patients.

]]>https://postcall.pub/post/https://mstdn.science/users/GMIK69/statuses/117163369922548230https://postcall.pub/post/https://mstdn.science/users/GMIK69/statuses/117163369922548230Wed, 26 Aug 2026 19:05:47 GMT